180 related articles for article (PubMed ID: 33885232)
1. Effects of polymyxin B hemoperfusion in patients with sepsis requiring continuous hemodiafiltration: Analysis of a nationwide administrative database in Japan.
Fujimori K; Tarasawa K; Fushimi K
Ther Apher Dial; 2021 Aug; 25(4):384-389. PubMed ID: 33885232
[TBL] [Abstract][Full Text] [Related]
2. Effects of Polymyxin B Hemoperfusion on Septic Shock Patients Requiring Noradrenaline: Analysis of a Nationwide Administrative Database in Japan.
Fujimori K; Tarasawa K; Fushimi K
Blood Purif; 2021; 50(4-5):560-565. PubMed ID: 33582663
[TBL] [Abstract][Full Text] [Related]
3. Potential survival benefit of polymyxin B hemoperfusion in patients with septic shock: a propensity-matched cohort study.
Nakamura Y; Kitamura T; Kiyomi F; Hayakawa M; Hoshino K; Kawano Y; Yamasaki R; Nishida T; Mizunuma M; Ishikura H;
Crit Care; 2017 Jun; 21(1):134. PubMed ID: 28592318
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of polymyxin B hemoperfusion for sepsis depends on the baseline SOFA score: a nationwide observational study.
Fujimori K; Tarasawa K; Fushimi K
Ann Intensive Care; 2021 Sep; 11(1):141. PubMed ID: 34568980
[TBL] [Abstract][Full Text] [Related]
5. Polymyxin B-immobilized fiber column direct hemoperfusion and continuous hemodiafiltration in premature neonates with systemic inflammatory response syndrome.
Maede Y; Ibara S; Tokuhisa T; Ishihara C; Hirakawa E; Matsui T; Takahashi D; Machigashira S; Minakami H
Pediatr Int; 2016 Nov; 58(11):1176-1182. PubMed ID: 27062100
[TBL] [Abstract][Full Text] [Related]
6. Direct hemoperfusion with polymyxin B-immobilized cartridge in severe sepsis due to intestinal perforation: hemodynamic findings and clinical considerations in anticoagulation therapy.
Maynar J; Martínez-Sagasti F; Herrera-Gutiérrez M; Martí F; Candel FJ; Belda J; Castaño S; Sanchez-Izquierdo JÁ
Rev Esp Quimioter; 2013 Jun; 26(2):151-8. PubMed ID: 23817653
[TBL] [Abstract][Full Text] [Related]
7. Continuous hemodiafiltration with polymyxin-B immobilized fiber is effective in patients with sepsis syndrome and acute renal failure.
Suzuki H; Nemoto H; Nakamoto H; Okada H; Sugahara S; Kanno Y; Moriwaki K
Ther Apher; 2002 Jun; 6(3):234-40. PubMed ID: 12109950
[TBL] [Abstract][Full Text] [Related]
8. Evidence and Perspectives on the Use of Polymyxin B-Immobilized Fiber Column Hemoperfusion among Critically Ill Patients.
Yamashita C; Moriyama K; Hasegawa D; Hara Y; Kuriyama N; Nakamura T; Shibata J; Komura H; Nishida O
Contrib Nephrol; 2018; 196():215-222. PubMed ID: 30041230
[TBL] [Abstract][Full Text] [Related]
9. Uncertain Clinical Effect of Polymyxin B Hemoperfusion in Patients with Septic Acute Kidney Injury Requiring Continuous Renal Replacement Therapy.
Lee JM; Baek SD; Kim TH; Jeon HR; Han JH; Chang JW
Shock; 2021 Oct; 56(4):551-556. PubMed ID: 33606479
[TBL] [Abstract][Full Text] [Related]
10. Exacerbation of prothrombin time-international normalized ratio before second polymyxin B cartridge hemoperfusion predicts poor outcome of patients with severe sepsis and/or septic shock.
Ishizuka M; Terasaki A; Kubota K
J Surg Res; 2016 Jan; 200(1):308-14. PubMed ID: 26319975
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of continuous hemodiafiltration using a polymethylmethacrylate membrane hemofilter after polymyxin B-immobilized fiber column therapy of septic shock.
Sakamoto Y; Mashiko K; Obata T; Matsumoto H; Hara Y; Kutsukata N; Yamamoto Y
ASAIO J; 2008; 54(1):129-32. PubMed ID: 18204329
[TBL] [Abstract][Full Text] [Related]
12. Identifying Septic Shock Populations Benefitting From Polymyxin B Hemoperfusion: A Prospective Cohort Study Incorporating a Restricted Cubic Spline Regression Model.
Nakata H; Yamakawa K; Kabata D; Umemura Y; Ogura H; Gando S; Shintani A; Shiraishi A; Saitoh D; Fujishima S; Mayumi T; Kushimoto S; Abe T; Shiino Y; Nakada TA; Tarui T; Hifumi T; Otomo Y; Okamoto K; Kotani J; Sakamoto Y; Sasaki J; Shiraishi SI; Takuma K; Tsuruta R; Hagiwara A; Masuno T; Takeyama N; Yamashita N; Ikeda H; Ueyama M; Fujimi S;
Shock; 2020 Nov; 54(5):667-674. PubMed ID: 32195922
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of polymyxin B hemoperfusion for septic shock: an observational study using a Japanese nationwide administrative database.
Fujimori K; Tarasawa K; Fushimi K
J Anesth Analg Crit Care; 2023 Feb; 3(1):4. PubMed ID: 37386542
[TBL] [Abstract][Full Text] [Related]
14. Changes of cytokines in direct endotoxin adsorption treatment on postoperative multiple organ failure.
Matsuno N; Ikeda T; Ikeda K; Hama K; Iwamoto H; Uchiyama M; Kozaki K; Narumi Y; Kikuchi K; Degawa H; Nagao T
Ther Apher; 2001 Feb; 5(1):36-9. PubMed ID: 11258608
[TBL] [Abstract][Full Text] [Related]
15. pH after the first session of direct hemoperfusion with polymyxin B-immobilized fibers predicts mortality in patients with sepsis and septic shock.
Okubo A; Nakashima A; Doi S; Ueno T; Sasaki K; Esaki T; Masaki T
Clin Exp Nephrol; 2018 Oct; 22(5):1167-1173. PubMed ID: 29478200
[TBL] [Abstract][Full Text] [Related]
16. Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial.
Klein DJ; Foster D; Walker PM; Bagshaw SM; Mekonnen H; Antonelli M
Intensive Care Med; 2018 Dec; 44(12):2205-2212. PubMed ID: 30470853
[TBL] [Abstract][Full Text] [Related]
17. Potential Survival Benefit of Polymyxin B Hemoperfusion in Septic Shock Patients on Continuous Renal Replacement Therapy: A Propensity-Matched Analysis.
Iwagami M; Yasunaga H; Noiri E; Horiguchi H; Fushimi K; Matsubara T; Yahagi N; Nangaku M; Doi K
Blood Purif; 2016; 42(1):9-17. PubMed ID: 26918904
[TBL] [Abstract][Full Text] [Related]
18. The effect of direct hemoperfusion with polymyxin B immobilized cartridge on meropenem in critically ill patients requiring renal support.
Singhan W; Vadcharavivad S; Areepium N; Wittayalertpanya S; Chaijamorn W; Srisawat N
J Crit Care; 2019 Jun; 51():71-76. PubMed ID: 30769293
[TBL] [Abstract][Full Text] [Related]
19. Direct hemoperfusion with polymyxin-B-immobilized fiber columns improves septic hypotension and reduces inflammatory mediators in septic patients with colorectal perforation.
Shimizu T; Hanasawa K; Sato K; Umeki M; Koga N; Naganuma T; Sato S; Shimonishi T; Ikeda T; Matsuno N; Ono S; Saitoh H; Satoh K; Otani Y; Endo Y; Eguchi Y; Tani T;
Langenbecks Arch Surg; 2009 Mar; 394(2):303-11. PubMed ID: 18685861
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review.
Cruz DN; Perazella MA; Bellomo R; de Cal M; Polanco N; Corradi V; Lentini P; Nalesso F; Ueno T; Ranieri VM; Ronco C
Crit Care; 2007; 11(2):R47. PubMed ID: 17448226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
